Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: fulvestrant
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)